Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 30th, 2011% (A. Kotok)
Aerospace engineers at MIT have developed an algorithm tested on real-life traffic data that predicts when an oncoming car is likely to run a red light at an intersection. The team’s research is expected to appear in an upcoming issue of the journal IEEE Transactions on Intelligent Transportation Systems.
Researchers from . . . → Read More: Algorithm Predicts Auto Traffic Intersection Violators
By Alan, on November 30th, 2011% Flowering sorghum (Agricultural Research Service/USDA)
The synthetic biology company Amyris Inc. in Emeryville, California and the French oil and gas company Total have agreed to collaborate on research and production of renewable fuels and chemicals. The agreement expands on an existing R&D relationship between the two companies.
Amyris and Total agreed to accelerate . . . → Read More: Biotech, Energy Company Partner on Renewable Fuel, Chemicals
By Alan, on November 29th, 2011% Students take soil samples in Cedar Rapids following the 2008 floods (University of Iowa).
Engineers at University of Iowa in Iowa City tested residential soil in nearby Cedar Rapids after the city flooded in 2008 and found industrial pollutants similar to those found at industrial sites. The findings appear in the online issue . . . → Read More: Contaminants in City Soil Found Similar to Industrial Sites
By Alan, on November 29th, 2011% Kansas State University in Manhattan says a team of its researchers has received a U.S. patent for their discovery of a synthetic peptide that helps dogs better fight pathogens, such as bacteria, viruses and fungi. The patent, “Antimicrobial Cathelicidin Peptides” was awarded by the U.S. Patent and Trademark Office to K-State nutritionist Tonatiuh Melgarejo, immunophysiologist . . . → Read More: Patent Awarded for Synthetic Canine Antimicrobial Peptide
By Alan, on November 29th, 2011% (National Institute of Drug Abuse)
Civitas Therapeutics Inc., a pharmaceutical company in Chelsea, Massachusetts, received a grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support the company’s lead drug candidate CVT-301. The amount of the grant to fund clinical development of the drug was not disclosed.
Parkinson’s disease occurs . . . → Read More: Fox Foundation to Fund Parkinson’s Drug Candidate Studies
By Alan, on November 29th, 2011% The European Patent Office (EPO) and State Intellectual Property Office (SIPO) of the People’s Republic of China have agreed to make possible translations of each other’s patents to the general public. The two organizations signed the agreement at their annual joint meeting, held this year in Chongqing, China.
The translations in English and Chinese, according . . . → Read More: European, Chinese Patent Offices Agree to Translations
By Alan, on November 28th, 2011% Graphene foam (Rensselaer Polytechnic Institute)
Engineers from the U.S. and China devised a foam substance made from graphene that is more sensitive in detecting potentially dangerous and explosive chemicals than current technologies. The researchers from Rensselaer Polytechnic Institute in Troy, New York and the Chinese Academy of Sciences in Shenyang published their research . . . → Read More: Graphene-Based Nanotech Gas Detector Developed
By Alan, on November 28th, 2011% (NASA)
National Institutes of Health has launched its electronic Research Materials (eRMa) Web site that aims to make it easier for prospects to locate and license findings from NIH’s labs for commercialization. The eRMA site was developed in response to President Obama’s order to agencies last month to speed the process of transferring . . . → Read More: NIH Unveils Web Site to Expedite Lab Technology Transfer
By Alan, on November 28th, 2011% The Ewing Marion Kauffman Foundation in Kansas City, Missouri has opened the next round of nominations for the Kauffman Junior Faculty Fellowship (KJFF) in Entrepreneurship Research. Each fellowship awards $40,000 to the fellow’s university to support the recipient’s research for two years.
The foundation plans to award up to seven KJFF grants to junior faculty . . . → Read More: Junior Faculty Entrepreneurship Fellowship Grants Open
By Alan, on November 28th, 2011% (WomensHealth.gov)
The pharmaceutical company Novartis in Basel, Switzerland says its drug Rasitrio has received approval from the European Commission (EC) for the treatment of hypertension or high blood pressure. The drug was designed for blood pressure patients who need multiple medications to treat their condition.
Rasitrio has the compound Rasilez, an inhibitor of . . . → Read More: European Commission Approval Granted for Blood Pressure Drug
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.